Physician profile
Kristin E Harrington
NPI 1538355409
$448.48
in general payments reported to CMS, 2019-2025
8 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.43 · 2022: $11.67 · 2024: $96.16 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $162.82 | 2025 | Novosorb Btm |
| Vericel Corporation | $119.10 | 2024-2025 | Epicel (Cultured Epidermal Autografts), Nexobrid |
| Avita Medical Americas, LLC | $50.38 | 2025 | Permeaderm, Recell, Cohealyx |
| Solventum Corporation | $44.90 | 2025 | Activ.A.C., V.A.C.Instill, Prevena |
| Smith+Nephew, INC. | $24.56 | 2024 | Stravix, Grafix Pl |
| Urgo Medical North America, LLC | $20.62 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Molnlycke Health Care US, LLC | $14.43 | 2021 | |
| Medela LLC | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Harrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.